|
|
||||||||
ANIMAL PRODUCTS |
Department of Animal Science, Iowa State University, Ames 50011
2 Correspondence: 2372 Kildee Hall (phone: 515-294-9126; fax: 515-294-9143; e-mail: slonerga{at}iastate.edu).
The objectives of this study were to determine the extent to which pH and ionic strength influence µ- and m-calpain activity and the inhibition of calpains by calpastatin. Calpastatin, µ-calpain, and m-calpain were purified from at-death porcine semimembranosus. µ-Calpain or m-calpain (0.45 U) were incubated with the calpain substrate Suc-Leu-Leu-Val-Tyr-7-amino-4-methyl coumarin in the presence of calpastatin (0, 0.15, or 0.30 U of calpain inhibitory activity) under the following pH and ionic strength conditions: pH 7.5 and 165 mM NaCl or 295 mM NaCl; pH 6.5 and 165 mM NaCl or 295 mM NaCl; and pH 6.0 and 165 mM NaCl or 295 mM NaCl. The reactions were initiated with addition of 100 µM (µ-calpain) or 1 mM CaCl2 (m-calpain), and calpain activity was recorded at 30 and 60 min. µ-Calpain had the greatest (P < 0.01) activity at pH 6.5 at each ionic strength. Higher ionic strength decreased µ-calpain activity (P < 0.01) at all pH conditions. Inhibition percent of µ-calpain by calpastatin was not affected by pH; however, it was influenced by ionic strength. Inhibition of µ-calpain by calpastatin was higher (P < 0.01) at 295 mM NaCl than at 165 mM NaCl when 0.3 units of calpastatin were included in the assay. Activity of m-calpain was greater (P < 0.01) at pH 7.5 than at pH 6.5. m-Calpain activity was not detected at pH 6.0. Inhibition of m-calpain was greater (P < 0.01) when 0.15 and 0.3 U calpastatin were added at pH 6.5 than 7.5 at 165 mM NaCl, whereas percentage inhibition of m-calpain was greater (P < 0.01) at 295 mM than 165 mM NaCl at pH 7.5 and 6.5. These observations provide new evidence that defines further the influence of pH decline and increased ionic strength on µ-calpain, m-calpain, and calpastatin activity, thereby helping to more accurately define a role for these enzymes in the process of postmortem tenderization.
Key Words: Calpain Calpastatin Ionic Strength Proteolysis pH
This article has been cited by other articles:
![]() |
K. M. Carnagey, E. J. Huff-Lonergan, S. M. Lonergan, A. Trenkle, R. L. Horst, and D. C. Beitz Use of 25-hydroxyvitamin D3 and dietary calcium to improve tenderness of beef from the round of beef cows J Anim Sci, July 1, 2008; 86(7): 1637 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Camou, J. A. Marchello, V. F. Thompson, S. W. Mares, and D. E. Goll Effect of postmortem storage on activity of {micro}- and m-calpain in five bovine muscles J Anim Sci, October 1, 2007; 85(10): 2670 - 2681. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Melloni, M. Averna, R. Stifanese, R. De Tullio, E. Defranchi, F. Salamino, and S. Pontremoli Association of Calpastatin with Inactive Calpain: A NOVEL MECHANISM TO CONTROL THE ACTIVATION OF THE PROTEASE? J. Biol. Chem., August 25, 2006; 281(34): 24945 - 24954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Inserte, D. Garcia-Dorado, V. Hernando, I. Barba, and J. Soler-Soler Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion Cardiovasc Res, May 1, 2006; 70(2): 364 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. M. Carlin, E. Huff-Lonergan, L. J. Rowe, and S. M. Lonergan Effect of oxidation, pH, and ionic strength on calpastatin inhibition of {micro}- and m-calpain J Anim Sci, April 1, 2006; 84(4): 925 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Murphy, R. J. Snow, and G. D. Lamb {micro}-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans Am J Physiol Cell Physiol, January 1, 2006; 290(1): C116 - C122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Inserte, D. Garcia-Dorado, V. Hernando, and J. Soler-Soler Calpain-Mediated Impairment of Na+/K+-ATPase Activity During Early Reperfusion Contributes to Cell Death After Myocardial Ischemia Circ. Res., September 2, 2005; 97(5): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |